Table 1. Clinical characteristics for exome-wide association study among Korean population.
| Variables | Prostate cancer(n = 1,001) | Control (n = 2,641) | Prostate Cancer II(n=514) | Control II (n=548) |
|---|---|---|---|---|
| Mean Age (yrs) ± SD | 66.32 ± 6.65 | 50.94 ± 8.50 | 69.08 ± 7.56 | 50.04 ±13.33 |
| Median PSA (ng/ml) ± SD | 9.19 ± 138.60 | N.A | 10.10 ± 648.92 | N.A. |
| Prostate volume (ml) ± SD | 37.48 ± 17.35 | N.A | N.A | N.A. |
| Body mass index (kg/m2) ± SD | 24.47 ± 8.23 | 24.25 ± 3.04 | ||
| Pathologic stage (n_%) | - | |||
| pT2 | 460 (56.1) | - | N.A | |
| pT3a | 271 (33.0) | - | N.A | |
| pT3b | 79 (9.6) | - | N.A | |
| pT4 | 10 (1.2) | - | N.A | |
| Gleason score (n_%) | - | |||
| 6 | 393 (39.3) | - | 43 (8.4) | |
| 7 | 411 (41.1) | - | 278 (54.1) | |
| 8 | 138 (13.8) | - | 86 (16.7) | |
| 9 | 47 (4.7) | - | 95 (18.5) | |
| 10 | 12 (1.2) | 12 (2.3) |
Abbreviations: SD = standard deviation; PSA = prostate specific antigen